You have 9 free searches left this month | for more free features.

nintedanib

Showing 1 - 25 of 67

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

Completed
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • Milton, Massachusetts
    Medicus Economics, LCC
Aug 8, 2022

Healthy Subjects Trial in Glendale (Nintedanib, AZD5055)

Not yet recruiting
  • Healthy Subjects
  • Glendale, United Kingdom
    Research Site
Dec 1, 2022

Healthy Trial in Neu-Ulm (Pirfenidone, GLPG4716, Nintedanib)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jun 1, 2022

Safety of Nintedanib in Real World in China

Not yet recruiting
  • Pulmonary Fibrosis
  • Beijing, China
    China-Japan Friendship Hospital
Jan 26, 2023

Idiopathic Pulmonary Fibrosis Trial in Shanghai (HEC585, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Shanghai, China
    Shanghai Xuhui Central Hospital
May 12, 2022

Lung-transplant Recipients Trial in Suresnes (Nintedanib, Placebo)

Recruiting
  • Lung-transplant Recipients
  • Nintedanib
  • Placebo
  • Suresnes, France
    Foch Hospital
May 2, 2022

Telangiectasia, Hereditary Hemorrhagic Trial in Lausanne (Nintedanib, Placebo)

Recruiting
  • Telangiectasia, Hereditary Hemorrhagic
  • Nintedanib
  • Placebo
  • Lausanne, Vaud, Switzerland
    Respiratory medicine Department, Lausanne University Hospital
Jul 22, 2022

Cough and Dyspnoea in Nintedanib-treated Connective Tissue

Not yet recruiting
  • Lung Diseases, Interstitial
  • Nintedanib
  • (no location specified)
Aug 15, 2022

INCHANGE - Nintedanib for Changes in Cough and Dyspnea in

Not yet recruiting
  • Lung Diseases, Interstitial
  • Nintedanib
  • (no location specified)
Aug 19, 2022

Lung Diseases, Interstitial (in Pediatric Populations), Childhood Interstitial Lung Disease (chILD) Trial (nintedanib)

Temporarily not available
  • Lung Diseases, Interstitial (in Pediatric Populations)
  • Childhood Interstitial Lung Disease (chILD)
  • nintedanib
  • (no location specified)
Jan 9, 2023

Idiopathic Pulmonary Fibrosis Trial in Seongnam-si (DWN12088, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Seongnam-si, Korea, Republic of
    Cha Unitersity Bundang Medical Center
Sep 22, 2021

Progressive Fibrosing Interstitial Lung Disease Trial in Morgantown (Nintedanib, Placebo)

Not yet recruiting
  • Progressive Fibrosing Interstitial Lung Disease
  • Nintedanib
  • Placebo
  • Morgantown, West Virginia
    West Virginia University Hospital
Sep 29, 2021

Trends in Quality of Life in Idiopathic Pulmonary Fibrosis Under

Active, not recruiting
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • Alexandroupoli, Greece
  • +9 more
Aug 22, 2022

NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Nintedanib
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 22, 2021

Cancer of Pancreas Trial in Dallas (Nintedanib)

Recruiting
  • Cancer of Pancreas
  • Nintedanib
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jul 29, 2021

Based on Medical Records That Looks at Characteristics of

Completed
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • +2 more
  • Plymouth, Pennsylvania
    Plymouth Meeting
Nov 12, 2021

Lung Diseases, Interstitial Trial in China (nintedanib, Placebo)

Recruiting
  • Lung Diseases, Interstitial
  • nintedanib
  • Placebo
  • Beijing, China
  • +12 more
Aug 9, 2022

Lung Diseases, Interstitial Trial in Belgium (nintedanib)

Available
  • Lung Diseases, Interstitial
  • nintedanib
  • Aalst, Belgium
  • +13 more
Aug 8, 2022

Pulmonary Fibrosis, Interstitial Lung Disease, Respiratory Disease Trial in United States (Nintedanib, Placebo)

Recruiting
  • Pulmonary Fibrosis
  • +2 more
  • Nintedanib
  • Placebo
  • Phoenix, Arizona
  • +7 more
Apr 7, 2022

NSCLC Trial in France, Germany (Docetaxel, Nintedanib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Angers, France
  • +3 more
Jan 11, 2021

Uterine Cervical Tumors Trial in Worldwide (Nintedanib, Placebo)

Active, not recruiting
  • Uterine Cervical Neoplasms
  • Nintedanib
  • Placebo
  • Bruxelles, Belgium
  • +31 more
Mar 1, 2022

Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in

Active, not recruiting
  • Stage IB Non-Small Cell Lung Carcinoma AJCC v7
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 4, 2022

Esophagogastric Adenocarcinoma Trial in United States (Nintedanib)

Completed
  • Esophagogastric Adenocarcinoma
  • Nintedanib
  • Basking Ridge, New Jersey
  • +5 more
Dec 30, 2020

Sarcoma, Soft Tissue Trial in Worldwide (Nintedanib, Ifosfamide)

Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
Sep 10, 2021

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients

Recruiting
  • Lung Diseases, Interstitial
  • Nintedanib
  • Aachen, Germany
  • +19 more
Jul 26, 2022